Introduction of minimally invasive inguinal lymph node dissections (MILND) for melanoma

The article by Jakub and colleagues describes the adoption of a minimally invasive inguinal lymph node dissection (MILND) for stage III melanoma patients in ten large-volume centers across the United States (1).